Legend Biotech Co. (NASDAQ:LEGN) Receives $81.22 Consensus Price Target from Brokerages
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) has been assigned an average rating of “Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Fourteen research analysts have rated the stock with a buy rating. The average 12 month target price among brokers that have covered the stock in […]
More Stories
SteelPeak Wealth LLC Has $2.21 Million Stock Holdings in First Trust NASDAQ Rising Dividend Achievers (NASDAQ:RDVY)
SteelPeak Wealth LLC grew its position in shares of First Trust NASDAQ Rising Dividend Achievers (NASDAQ:RDVY – Free Report) by...
New York State Teachers Retirement System Sells 4,692 Shares of Autodesk, Inc. (NASDAQ:ADSK)
New York State Teachers Retirement System lowered its position in Autodesk, Inc. (NASDAQ:ADSK – Free Report) by 2.3% in the...
SteelPeak Wealth LLC Has $974,000 Stock Holdings in FactSet Research Systems Inc. (NYSE:FDS)
SteelPeak Wealth LLC reduced its position in shares of FactSet Research Systems Inc. (NYSE:FDS – Free Report) by 19.4% in...
SteelPeak Wealth LLC Sells 151 Shares of Expedia Group, Inc. (NASDAQ:EXPE)
SteelPeak Wealth LLC lessened its position in shares of Expedia Group, Inc. (NASDAQ:EXPE – Free Report) by 2.0% in the...
Pentair plc (NYSE:PNR) Shares Sold by Golden State Equity Partners
Golden State Equity Partners trimmed its holdings in shares of Pentair plc (NYSE:PNR – Free Report) by 31.6% in the...
Stifel Nicolaus Forecasts Strong Price Appreciation for Hut 8 (NASDAQ:HUT) Stock
Hut 8 (NASDAQ:HUT – Free Report) had its price target raised by Stifel Nicolaus from $15.00 to $18.00 in a...